<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: kidney transplant patients</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>US sues Novartis in NY again, cites doc kickbacks</title>
   	 <description>The U.S. government sued Novartis Pharmaceuticals Corp. again on Friday, saying it paid kickbacks for a decade to doctors to steer patients toward its drugs, sometimes disguising fishing trips off the Florida coast and trips to Hooters restaurants as speaking engagements for the doctors.</description>
     <link>http://medicalxpress.com/news/2013-04-sues-novartis-ny-cites-doc.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 26 Apr 2013 19:04:16 EST</pubDate>
	 <guid isPermaLink="false">news286221850</guid>
	 
</item>
<item>
     <title>NY lawsuit accuses Novartis of health care fraud</title>
   	 <description>The U.S. government sued Novartis Pharmaceuticals Corp. Tuesday, claiming it gave kickbacks to pharmacies to switch kidney transplant patients from competitors' drugs to its own.</description>
     <link>http://medicalxpress.com/news/2013-04-ny-lawsuit-accuses-novartis-health.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 24 Apr 2013 04:40:02 EST</pubDate>
	 <guid isPermaLink="false">news285996589</guid>
	 
</item>
<item>
     <title>Promising breakthrough for transplant patients</title>
   	 <description>A team led by Dr. Marie-Josée Hébert from the University of Montreal Hospital Research Centre (CRCHUM) has discovered a new cause of organ rejection in some kidney transplant patients. Her team has identified a new class of antibodies – anti-LG3 – which when activated lead to severe rejection episodes associated with a high rate of organ loss. This discovery, which holds promise for organ recipients, was published in the online version of the American Journal of Transplantation.</description>
     <link>http://medicalxpress.com/news/2013-02-breakthrough-transplant-patients.html</link>
	 <category>Surgery</category>
	 <pubDate>Wed, 27 Feb 2013 11:30:01 EST</pubDate>
	 <guid isPermaLink="false">news281184112</guid>
	 
</item>
<item>
     <title>Are some patients too heavy for a new kidney?</title>
   	 <description>In a research review article published in the American Journal of Nephrology, Saint Louis University investigators examined data from multiple studies to better understand how obesity, an epidemic in the U.S., impacts kidney transplant patients. The authors report that, even as some connections between weight and health outcomes are unknown or contradictory, there is evidence that obese kidney transplant patients don't do as well after surgery, experiencing more adverse outcomes, including wound infections, delayed graft function, graft failure, cardiac disease and increased costs.</description>
     <link>http://medicalxpress.com/news/2013-01-patients-heavy-kidney.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 14 Jan 2013 12:44:20 EST</pubDate>
	 <guid isPermaLink="false">news277389754</guid>
	 
</item>
<item>
     <title>Drug class linked to worse outcomes after transplant</title>
   	 <description>(HealthDay)—Kidney transplant patients who receive mammalian target of rapamycin (mTOR) inhibitors after transplant have a greater probability of death or transplant failure than patients receiving calcineurin inhibitors, according to a study published online Oct. 1 in the American Journal of Transplantation.</description>
     <link>http://medicalxpress.com/news/2012-10-drug-class-linked-worse-outcomes.html</link>
	 <category>Surgery</category>
	 <pubDate>Sun, 14 Oct 2012 14:30:01 EST</pubDate>
	 <guid isPermaLink="false">news269414813</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/drugclasslin.jpg" width="90" height="90" />
</item>
<item>
     <title>Quick physical exam can reduce wait for a transplant by half a year</title>
   	 <description>(Medical Xpress) -- A one-day coordinated evaluation can significantly reduce the amount of time it takes to be put on a kidney transplant waitlist, according to a new study from Yale School of Medicine. The study appears in the American Journal of Kidney Diseases.</description>
     <link>http://medicalxpress.com/news/2012-08-quick-physical-exam-transplant-year.html</link>
	 <category>Other</category>
	 <pubDate>Fri, 03 Aug 2012 07:56:42 EST</pubDate>
	 <guid isPermaLink="false">news263199394</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/quickphysica.jpg" width="90" height="90" />
</item>
<item>
     <title>Test approved to help treat common infection in transplant patients</title>
   	 <description>(HealthDay) -- The first DNA test to help doctors treat a common viral infection in people who have had a solid organ transplant has been approved by the U.S. Food and Drug Administration.</description>
     <link>http://medicalxpress.com/news/2012-07-common-infection-transplant-patients.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 05 Jul 2012 18:00:01 EST</pubDate>
	 <guid isPermaLink="false">news260726189</guid>
	 
</item>
<item>
     <title>Use of stem cells for adults receiving related donor kidney transplants appears to improve outcomes</title>
   	 <description>Among patients with end-stage renal disease undergoing living-related kidney transplants, the use of bone-marrow derived mesenchymal (cells that can differentiate into a variety of cell types) stem cells instead of antibody induction therapy resulted in a lower incidence of acute rejection, decreased risk of opportunistic infection, and better estimated kidney function at 1 year, according to a study in the March 21 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2012-03-stem-cells-adults-donor-kidney.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 20 Mar 2012 16:29:21 EST</pubDate>
	 <guid isPermaLink="false">news251479748</guid>
	 
</item>
<item>
     <title>Stop taking steroids: Kidney transplant recipients may not need long-term prednisone</title>
   	 <description>Rapid discontinuation of the immunosuppressive steroid prednisone after a kidney transplant can help prevent serious side effects, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Also, doing so does not appear to jeopardize the long-term survival of transplant patients and their new organs.</description>
     <link>http://medicalxpress.com/news/2012-01-steroids-kidney-transplant-recipients-long-term.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 26 Jan 2012 17:00:05 EST</pubDate>
	 <guid isPermaLink="false">news246806737</guid>
	 
</item>
<item>
     <title>Study: Mycophenolate is superior to azathioprine as treatment for lupus nephritis</title>
   	 <description>A new large, international study finds that the immunosuppressant drug mycophenolate mofetil is superior to azathioprine, an older immunosuppressant, as a maintenance therapy for lupus nephritis.</description>
     <link>http://medicalxpress.com/news/2011-11-mycophenolate-superior-azathioprine-treatment-lupus.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 16 Nov 2011 17:39:38 EST</pubDate>
	 <guid isPermaLink="false">news240687558</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/studymycophe.jpg" width="90" height="90" />
</item>
<item>
     <title>Substitution of brand name with generic drug proves safe for transplant recipients</title>
   	 <description>A new study published in the American Journal of Transplantation reveals that substitution of a brand name immunosuppressive drug with a generic (manufactured by Sandoz) for preventing rejection of transplanted organs appears to be safe for transplant recipients.</description>
     <link>http://medicalxpress.com/news/2011-09-substitution-brand-drug-safe-transplant.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 13 Sep 2011 11:28:01 EST</pubDate>
	 <guid isPermaLink="false">news235132066</guid>
	 
</item>
<item>
     <title>Best post-transplant drug regimen identified for patients with new kidneys</title>
   	 <description>For the thousands of patients who receive kidney transplants in the United States each year, preventing organ rejection without compromising other aspects of health requires a delicate balance of medications. Immunosuppresive drugs that protect transplanted organs can also cause serious side effects, including compromising patients' immunity to infection, cancer, and other threats. Finding the best combination and dosage of drugs has often proved difficult for physicians.</description>
     <link>http://medicalxpress.com/news/2011-07-post-transplant-drug-regimen-patients-kidneys.html</link>
	 <category>Other</category>
	 <pubDate>Fri, 29 Jul 2011 03:17:05 EST</pubDate>
	 <guid isPermaLink="false">news231128211</guid>
	 
</item>
<item>
     <title>Study examines factors in pediatric kidney transplant rejection</title>
   	 <description>Avoiding HLA-DR mismatching appears to be beneficial in pediatric kidney transplant patients, however the likelihood of finding a matching donor must be considered against the wait time for a possible donation, according to a report in the July issue of Archives of Surgery.</description>
     <link>http://medicalxpress.com/news/2011-07-factors-pediatric-kidney-transplant.html</link>
	 <category>Other</category>
	 <pubDate>Mon, 18 Jul 2011 16:40:04 EST</pubDate>
	 <guid isPermaLink="false">news230225991</guid>
	 
</item>
<item>
     <title>Long-term study shows that kidney transplants are faring better than previously reported</title>
   	 <description>A new study from Mayo Clinic, the largest long-term study of kidney transplant recipients published to date, demonstrates that progressive damage to kidney transplants may be less common and less severe than previously reported.</description>
     <link>http://medicalxpress.com/news/2011-04-long-term-kidney-transplants-faring-previously.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 07 Apr 2011 15:22:21 EST</pubDate>
	 <guid isPermaLink="false">news221408523</guid>
	 
</item>


</channel>
</rss>
